# Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants

> **NCT04567667** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 9 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C] BMS-986278
- **DRUG:** Kinevac®

## Key facts

- **NCT ID:** NCT04567667
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2021-04-11
- **Final completion:** 2021-04-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04567667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04567667, "Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04567667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*